Phase 3 trial in nearly 500 advanced disease patients found combination therapy using Blenrep more effective at extending life than Darzalex.| Rare Cancer News
Steve Bryson is a science writer for Myeloma Research News with a PhD in biochemistry. He covers the latest news and information on a variety of myeloma topics.| Rare Cancer News